Education
About Us
Working with TipRanks
Follow Us
Holista Colltech Limited (AU:HCT)
:HCT
RESEARCH TOOLSreports
HCT Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.07
Previous CloseN/A
Volume829.52K
Average Volume (3M)245.10K
Market Cap
AU$17.72M
Enterprise ValueAU$9.13M
Total Cash (Recent Filing)AU$21.72K
Total Debt (Recent Filing)AU$1.77M
Price to Earnings (P/E)―
Beta-0.33
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding285,766,720
10 Day Avg. Volume113,099
30 Day Avg. Volume245,105
Financial Highlights & Ratios
PEG Ratio-0.42
Price to Book (P/B)2.84
Price to Sales (P/S)0.00
P/FCF Ratio-6.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Holista Colltech Limited News
PremiumCompany Announcements
Holista Colltech Updates on Nano-Collagen Licensing Discussions
PremiumCompany Announcements
Holista Colltech Shifts Focus to Advanced Nano-Collagen Applications
PremiumCompany Announcements
Holista Colltech Appoints New Director to Strengthen Leadership
PremiumCompany Announcements
Holista Colltech Announces Strategic Board AppointmentsPremiumCompany Announcements
Holista Colltech Addresses ASX Price Query
PremiumCompany Announcements
Holista Colltech Limited Announces 2025 Annual General Meeting
PremiumCompany Announcements
Holista Colltech Resolves ASIC Matter and Focuses on RecoveryHCT FAQ
What was Holista Colltech Limited’s price range in the past 12 months?
Holista Colltech Limited lowest share price was <AU$0.01 and its highest was AU$0.07 in the past 12 months.
What is Holista Colltech Limited’s market cap?
Holista Colltech Limited’s market cap is AU$17.72M.
When is Holista Colltech Limited’s upcoming earnings report date?
Holista Colltech Limited’s upcoming earnings report date is Aug 29, 2025 which is in 74 days.
How were Holista Colltech Limited’s earnings last quarter?
Holista Colltech Limited released its earnings results on Feb 27, 2025. The company reported AU$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.003.
Is Holista Colltech Limited overvalued?
According to Wall Street analysts Holista Colltech Limited’s price is currently Overvalued.
Does Holista Colltech Limited pay dividends?
Holista Colltech Limited does not currently pay dividends.
What is Holista Colltech Limited’s EPS estimate?
Holista Colltech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Holista Colltech Limited have?
Holista Colltech Limited has 285,766,720 shares outstanding.
What happened to Holista Colltech Limited’s price movement after its last earnings report?
Holista Colltech Limited reported an EPS of AU$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Holista Colltech Limited?
Currently, no hedge funds are holding shares in AU:HCT
Holista Colltech Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:HCT Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
500.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.27%
Trailing 12-Months
Company Description
Holista Colltech Limited
Holista Colltech Limited (HCT) is a biotechnology company specializing in health and wellness solutions. Operating in sectors such as food ingredients, dietary supplements, and pharmaceutical-grade collagen, Holista Colltech focuses on developing innovative products aimed at enhancing health and improving quality of life. The company's core offerings include low-GI (glycemic index) food ingredients, natural dietary supplements, and collagen-based skincare products.
Technical Analysis
Actinogen Medical
―
Cynata Therapeutics Limited
―
Vectus Biosystems Limited
―
Botanix Pharmaceuticals Limited
―